Abeer Alanazi: Secondary Stroke Prevention in Atrial Fibrillation
Abeer Alanazi, Senior Clinical Pharmacist at King Fahad Specialist Hospital Dammam, Member of European Stroke Organisation (ESO), shared a post on LinkedIn about a recent article by Kazumi Kimura et al. published in JAMA Neurology, adding:
“Catheter Ablation and Oral Anticoagulation for Secondary Stroke Prevention in Atrial Fibrillation
The STABLED Randomized Clinical Trial.”
Title: Catheter Ablation and Oral Anticoagulation for Secondary Stroke Prevention in Atrial Fibrillation
Authors: Kazumi Kimura, Yasuhiro Nishiyama, Yu-ki Iwasaki, Wataru Shimizu, Kazunori Toyoda, Yuki Sakamoto, Takehiro Katano, Teppei Yamamoto, Masataka Takeuchi, Kenta Kumagai, Kazuma Tsuto, Kaoru Sugi, Kengo Kusano, Masatoshi Koga, Seiji Okubo, Takahiro Sato, Hirotoshi Hamaguchi, Akihiro Yoshida, Ayako Kuriki, Kaoru Tanno, Kazuo Kitagawa, Nobuhisa Hagiwara, Hiroyuki Daida, Yasuyuki Iguchi, Shigeru Fujimoto, Susumu Miyamoto, Masayuki Fukuzawa, Masako Sugimoto, Atsushi Takita, Toshiaki Otsuka, Ken Okumura.
Stay updated on all scientific advances with Hemostasis Today.
-
May 6, 2026, 12:12Mona Ranade: Insights from a Medeloop Analytics Study Evaluate Catheter-Directed Therapy in Pulmonary Embolism
-
May 6, 2026, 11:50Natalie L. Baggio: A 24/7 Neurointerventional Stroke Care at Corewell Health Is Now a Reality
-
May 6, 2026, 11:30Paula Caporal: Consensus on the Diagnosis and Management of Pediatric Stroke in Argentina
-
May 6, 2026, 11:14Li Khim Kwah: Proud for the Development of The New Singapore Stroke Rehabilitation Guideline
-
May 6, 2026, 10:55Hugo Antonio Romo Rubio: A New Paradigm in Treatment for Hemophilia A from FRONTIERS2 Phase 3 Study
-
May 6, 2026, 10:40Ifeanyichukwu Ifechidere: Why INR Can Be Dangerously Misleading
-
May 6, 2026, 02:58Limiaa Babikir: What Is Polyspecific DAT?
-
May 6, 2026, 02:47Karen Rollinson: Connecting with so Many Families and Advocates at HFA 2026
-
May 6, 2026, 02:38Moustafa Abdou: Is the Bone Marrow Examination Still the ‘Gold Standard’?